Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com
Investment analysts at StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Up 20.0 % Shares of NYSE NAVB opened at $0.00 on Tuesday. Navidea Biopharmaceuticals has a 1 year low […]
Investment analysts at StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Up 20.0 % Shares of NYSE NAVB opened at $0.00 on Tuesday. Navidea Biopharmaceuticals has a 1 year low […]
